Copyright Reports & Markets. All rights reserved.

Global Choroidal Neovascularization Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Choroidal Neovascularization Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Choroidal Neovascularization Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Choroidal Neovascularization Market Size Growth Rate by Type
    • 1.4.2 Intravenous
    • 1.4.3 Intravitreal
  • 1.5 Market by Application
    • 1.5.1 Global Choroidal Neovascularization Market Size Growth Rate by Application
    • 1.5.2 Extreme Myopia
    • 1.5.3 Malignant Myopic Degeneration
    • 1.5.4 Age-Related Developments
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Choroidal Neovascularization Market Size, Estimates and Forecasts
    • 2.1.1 Global Choroidal Neovascularization Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Choroidal Neovascularization Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Choroidal Neovascularization Production Estimates and Forecasts 2015-2026
  • 2.2 Global Choroidal Neovascularization, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Choroidal Neovascularization Manufacturers Geographical Distribution
  • 2.4 Key Trends for Choroidal Neovascularization Markets & Products
  • 2.5 Primary Interviews with Key Choroidal Neovascularization Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Choroidal Neovascularization Manufacturers by Production Capacity
    • 3.1.1 Global Top Choroidal Neovascularization Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Choroidal Neovascularization Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Choroidal Neovascularization Manufacturers Market Share by Production
  • 3.2 Global Top Choroidal Neovascularization Manufacturers by Revenue
    • 3.2.1 Global Top Choroidal Neovascularization Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Choroidal Neovascularization Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Choroidal Neovascularization Revenue in 2019
  • 3.3 Global Choroidal Neovascularization Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Choroidal Neovascularization Production by Regions

  • 4.1 Global Choroidal Neovascularization Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Choroidal Neovascularization Regions by Production (2015-2020)
    • 4.1.2 Global Top Choroidal Neovascularization Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Choroidal Neovascularization Production (2015-2020)
    • 4.2.2 North America Choroidal Neovascularization Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Choroidal Neovascularization Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Choroidal Neovascularization Production (2015-2020)
    • 4.3.2 Europe Choroidal Neovascularization Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Choroidal Neovascularization Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Choroidal Neovascularization Production (2015-2020)
    • 4.4.2 China Choroidal Neovascularization Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Choroidal Neovascularization Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Choroidal Neovascularization Production (2015-2020)
    • 4.5.2 Japan Choroidal Neovascularization Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Choroidal Neovascularization Import & Export (2015-2020)

5 Choroidal Neovascularization Consumption by Region

  • 5.1 Global Top Choroidal Neovascularization Regions by Consumption
    • 5.1.1 Global Top Choroidal Neovascularization Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Choroidal Neovascularization Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Choroidal Neovascularization Consumption by Application
    • 5.2.2 North America Choroidal Neovascularization Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Choroidal Neovascularization Consumption by Application
    • 5.3.2 Europe Choroidal Neovascularization Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Choroidal Neovascularization Consumption by Application
    • 5.4.2 Asia Pacific Choroidal Neovascularization Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Choroidal Neovascularization Consumption by Application
    • 5.5.2 Central & South America Choroidal Neovascularization Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Choroidal Neovascularization Consumption by Application
    • 5.6.2 Middle East and Africa Choroidal Neovascularization Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Choroidal Neovascularization Market Size by Type (2015-2020)
    • 6.1.1 Global Choroidal Neovascularization Production by Type (2015-2020)
    • 6.1.2 Global Choroidal Neovascularization Revenue by Type (2015-2020)
    • 6.1.3 Choroidal Neovascularization Price by Type (2015-2020)
  • 6.2 Global Choroidal Neovascularization Market Forecast by Type (2021-2026)
    • 6.2.1 Global Choroidal Neovascularization Production Forecast by Type (2021-2026)
    • 6.2.2 Global Choroidal Neovascularization Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Choroidal Neovascularization Price Forecast by Type (2021-2026)
  • 6.3 Global Choroidal Neovascularization Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Choroidal Neovascularization Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Choroidal Neovascularization Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 Pfizer Inc.
    • 8.1.1 Pfizer Inc. Corporation Information
    • 8.1.2 Pfizer Inc. Overview
    • 8.1.3 Pfizer Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 Pfizer Inc. Product Description
    • 8.1.5 Pfizer Inc. Related Developments
  • 8.2 F. Hoffmann-La Roche Ltd.
    • 8.2.1 F. Hoffmann-La Roche Ltd. Corporation Information
    • 8.2.2 F. Hoffmann-La Roche Ltd. Overview
    • 8.2.3 F. Hoffmann-La Roche Ltd. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 F. Hoffmann-La Roche Ltd. Product Description
    • 8.2.5 F. Hoffmann-La Roche Ltd. Related Developments
  • 8.3 Novartis AG
    • 8.3.1 Novartis AG Corporation Information
    • 8.3.2 Novartis AG Overview
    • 8.3.3 Novartis AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Novartis AG Product Description
    • 8.3.5 Novartis AG Related Developments
  • 8.4 Regeneron Pharmaceuticals Inc.
    • 8.4.1 Regeneron Pharmaceuticals Inc. Corporation Information
    • 8.4.2 Regeneron Pharmaceuticals Inc. Overview
    • 8.4.3 Regeneron Pharmaceuticals Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Regeneron Pharmaceuticals Inc. Product Description
    • 8.4.5 Regeneron Pharmaceuticals Inc. Related Developments
  • 8.5 Bayer AG
    • 8.5.1 Bayer AG Corporation Information
    • 8.5.2 Bayer AG Overview
    • 8.5.3 Bayer AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Bayer AG Product Description
    • 8.5.5 Bayer AG Related Developments
  • 8.6 QLT Inc.
    • 8.6.1 QLT Inc. Corporation Information
    • 8.6.2 QLT Inc. Overview
    • 8.6.3 QLT Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 QLT Inc. Product Description
    • 8.6.5 QLT Inc. Related Developments
  • 8.7 Sanwa Kagaku Kenkyusho Co. Ltd.
    • 8.7.1 Sanwa Kagaku Kenkyusho Co. Ltd. Corporation Information
    • 8.7.2 Sanwa Kagaku Kenkyusho Co. Ltd. Overview
    • 8.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 Sanwa Kagaku Kenkyusho Co. Ltd. Product Description
    • 8.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Related Developments
  • 8.8 Promedior Inc.
    • 8.8.1 Promedior Inc. Corporation Information
    • 8.8.2 Promedior Inc. Overview
    • 8.8.3 Promedior Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 Promedior Inc. Product Description
    • 8.8.5 Promedior Inc. Related Developments
  • 8.9 Bausch Health
    • 8.9.1 Bausch Health Corporation Information
    • 8.9.2 Bausch Health Overview
    • 8.9.3 Bausch Health Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 Bausch Health Product Description
    • 8.9.5 Bausch Health Related Developments
  • 8.10 Gilead Sciences Inc
    • 8.10.1 Gilead Sciences Inc Corporation Information
    • 8.10.2 Gilead Sciences Inc Overview
    • 8.10.3 Gilead Sciences Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 Gilead Sciences Inc Product Description
    • 8.10.5 Gilead Sciences Inc Related Developments

9 Choroidal Neovascularization Production Forecast by Regions

  • 9.1 Global Top Choroidal Neovascularization Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Choroidal Neovascularization Regions Forecast by Production (2021-2026)
  • 9.3 Key Choroidal Neovascularization Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Choroidal Neovascularization Consumption Forecast by Region

  • 10.1 Global Choroidal Neovascularization Consumption Forecast by Region (2021-2026)
  • 10.2 North America Choroidal Neovascularization Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Choroidal Neovascularization Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Choroidal Neovascularization Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Choroidal Neovascularization Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Choroidal Neovascularization Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Choroidal Neovascularization Sales Channels
    • 11.2.2 Choroidal Neovascularization Distributors
  • 11.3 Choroidal Neovascularization Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Choroidal Neovascularization Industry
  • 12.2 Market Trends
  • 12.3 Market Opportunities and Drivers
  • 12.4 Market Challenges
  • 12.5 Choroidal Neovascularization Market Risks/Restraints
  • 12.6 Porter's Five Forces Analysis

13 Key Finding in The Global Choroidal Neovascularization Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Choroidal Neovascularization market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Choroidal Neovascularization market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Choroidal Neovascularization market is segmented into
    Intravenous
    Intravitreal

    Segment by Application, the Choroidal Neovascularization market is segmented into
    Extreme Myopia
    Malignant Myopic Degeneration
    Age-Related Developments

    Regional and Country-level Analysis
    The Choroidal Neovascularization market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Choroidal Neovascularization market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
    Competitive Landscape and Choroidal Neovascularization Market Share Analysis

    Choroidal Neovascularization market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Choroidal Neovascularization by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Choroidal Neovascularization business, the date to enter into the Choroidal Neovascularization market, Choroidal Neovascularization product introduction, recent developments, etc.
    The major vendors covered:
    Pfizer Inc.
    F. Hoffmann-La Roche Ltd.
    Novartis AG
    Regeneron Pharmaceuticals Inc.
    Bayer AG
    QLT Inc.
    Sanwa Kagaku Kenkyusho Co. Ltd.
    Promedior Inc.
    Bausch Health
    Gilead Sciences Inc

    Buy now